In 1999, the Special Committee for Environmental Medicine affiliated to the Federal Association of Doctors in the German public health service, prepared a consensus paper on the latter's request entitled "Environmental medicine in the public health service -- a social role and its consequences: propositions with regard to the situation, aims, strategies, and opportunities for action". The propositions provide guidelines to public health departments for implementing the "Environment and Health" action programme launched by the Federal Ministry of Environmental Protection and the Federal Ministry of Health. Joint action by health and environmental authorities on the municipal, state and federal levels is considered essential. Furthermore, the comprehensive knowledge and expertise available within the public health service, including its in-depth knowledge of local and regional environmental pollution, should be further utilized in order to clarify cause and effect relationships and to initiate necessary action for minimizing any imminent risks. Environment-related public health protection is one of the major responsibilities of the public health departments within their general responsibility to provide public health care and ensure disease prevention. Doctors in private practices specializing in environmental medicine and public health departments' counselling centres for environmental medicine work closely together in terms of patient care and citizens' counselling in order to identify potential causes of environment-related health problems in the population. They issue recommendations on how to live a healthy life. Furthermore, they utilize available data and information for health policy directions. In this regard, health and environmental findings provide an important basis for an appropriate response to current developments based on the correct assessment of a particular situation, and for raising public awareness of preventive measures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00103-005-1135-1 | DOI Listing |
Ecotoxicol Environ Saf
January 2025
Hunan Province Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical school, University of South China, Hengyang, Hunan 421001, China. Electronic address:
Microcystin LR (MC-LR) pollution is a serious threat to aquatic ecosystems and public health in China and is an environmental problem that urgently needs to be solved. However, few studies have investigated the anaerobic degradation pathway and related molecular biological mechanisms of MC-LR. In this study, a bacterium capable of degrading MC-LR with a degradation efficiency of 0.
View Article and Find Full Text PDFDrug Alcohol Depend
January 2025
RAND, Boston, MA, United States. Electronic address:
Importance: States have implemented multiple policies likely to influence opioid prescribing; few national general population studies examine those policies' effects on per-capita opioid morphine milligram equivalents (MME) dispensed.
Objective: To examine state policies' effects on opioids per-capita MMEs dispensed at retail pharmacies.
Design: A longitudinal study of associations between MME per capita and implementation of policy interventions at different times across states.
Eur J Radiol
January 2025
Department of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA. Electronic address:
Purpose: To evaluate the feasibility of aortoiliac CT-Angiography (CTA) using dual-source photon-counting detector (PCD)-CT with minimal iodine dose.
Methods: This IRB-approved, single-center prospective study enrolled patients with indications for aortoiliac CTA from December 2022 to March 2023. All scans were performed using a first-generation dual-source PCD-CT.
Pediatr Infect Dis J
January 2025
Public Health Secretariat, Department of Health, Generalitat de Catalunya, Barcelona, Spain.
Background: In Catalonia, infants <6 months old were eligible to receive nirsevimab, a novel monoclonal antibody against respiratory syncytial virus (RSV). We aimed to analyze nirsevimab's effectiveness in hospital-related outcomes of the seasonal cohort (born during the RSV epidemic from October to January 2024) and compared them with the catch-up cohort (born from April to September 2023).
Methods: Retrospective cohort study of all infants born between October 1, 2023, and January 21, 2024, according to their immunization with nirsevimab (immunized and nonimmunized).
Pediatr Infect Dis J
January 2025
From the GPIP, Groupe de pathologie infectieuse pédiatrique, Créteil, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!